Cargando…
Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular Carcinoma
Use of immune checkpoint inhibitors (ICIs) in hepatocellular carcinoma (HCC) has been partially successful. However, most HCC patients do not respond to immunotherapy. HCC has been shown to induce several immune suppressor mechanisms in patients. These suppressor mechanisms include involvement of my...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Liver Cancer Association
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035699/ https://www.ncbi.nlm.nih.gov/pubmed/37383056 http://dx.doi.org/10.17998/jlc.20.1.1 |